Technical Analysis for BWAY - Brainsway Ltd.

Grade Last Price % Change Price Change
grade D 10.1003 -2.95% -0.31
BWAY closed down 2.95 percent on Monday, July 15, 2019, on 57 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A Down Down
See historical BWAY trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
Fell Below 50 DMA Bearish 0.00%
Expansion Pivot Sell Setup Bearish Swing Setup 0.00%
Multiple of Ten Bullish Other 0.00%
Gapped Down Weakness 0.00%
Crossed Above 50 DMA Bullish -2.95%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -2.95%
Narrow Range Bar Range Contraction -2.95%
NR7 Range Contraction -2.95%
Inside Day Range Contraction -2.95%

Older signals for BWAY ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Brainsway is a commercial stage medical device company focused on the development and sale of non-invasive neuromodulation products using the Company’s proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder (MDD) and obsessive-compulsive disorder (OCD), for which Brainsway received marketing authorization from the U.S. Food and Drug Administration (FDA) in 2013 (for MDD) and in August 2018 (for OCD). Brainsway is currently conducting clinical trials of Deep TMS in other psychiatric, neurological and addiction disorders, including smoking cessation and post-traumatic stress disorder, and is planning trials for opioid addiction, fatigue in multiple sclerosis (MS) and post-stroke rehabilitation.
Neuroscience Multiple Sclerosis Psychiatry Major Depressive Disorder Neuromodulation Neurophysiology Neurotechnology Obsessive Compulsive Disorder Treatment Of Major Depressive Disorder Neuropsychology Post Traumatic Stress Disorder Treatment Of Depression Fatigue
Is BWAY a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 12.3899
52 Week Low 8.0
Average Volume 10,066
200-Day Moving Average 0.0
50-Day Moving Average 10.2432
20-Day Moving Average 10.1851
10-Day Moving Average 10.3745
Average True Range 0.4259
ADX 20.36
+DI 16.8014
-DI 33.2472
Chandelier Exit (Long, 3 ATRs ) 9.5723
Chandelier Exit (Short, 3 ATRs ) 9.807699999999999
Upper Bollinger Band 11.0652
Lower Bollinger Band 9.305
Percent B (%b) 0.45
BandWidth 17.282108
MACD Line 0.0602
MACD Signal Line 0.0545
MACD Histogram 0.0057
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 11.36
Resistance 3 (R3) 11.30 10.83 11.15
Resistance 2 (R2) 10.83 10.51 10.86 11.08
Resistance 1 (R1) 10.46 10.31 10.23 10.52 11.01
Pivot Point 9.99 9.99 9.87 10.02 9.99
Support 1 (S1) 9.62 9.67 9.39 9.68 9.19
Support 2 (S2) 9.15 9.47 9.18 9.12
Support 3 (S3) 8.78 9.15 9.05
Support 4 (S4) 8.84